1,205
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Genetic liability between COVID-19 and pre-eclampsia/eclampsia: a Mendelian randomization study

, , , & ORCID Icon
Article: 2285757 | Received 25 Aug 2023, Accepted 13 Nov 2023, Published online: 28 Nov 2023

References

  • Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323–7. doi: 10.1016/S2214-109X(14)70227-X
  • Chappell LC, Cluver CA, Kingdom J, et al. Pre-eclampsia. Lancet. 2021;398:341–354. doi: 10.1016/S0140-6736(20)32335-710297
  • Chaiworapongsa T, Chaemsaithong P, Yeo L, et al. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10(8):466–480. doi: 10.1038/nrneph.2014.102
  • Erez O, Romero R, Jung E, et al. Preeclampsia and eclampsia: the conceptual evolution of a syndrome. Am J Obstet Gynecol. 2022;226(2):S786–S803. doi: 10.1016/j.ajog.2021.12.001
  • Konopka T, Zakrzewska A. Periodontitis and risk for preeclampsia — a systematic review. Ginekol Pol. 2020;91(3):158–164. doi: 10.5603/GP.2020.0024
  • Nourollahpour SM, Behboodi MZ, Adam I, et al. Human infectious diseases and risk of preeclampsia: an updated review of the literature. Infection. 2017;45(5):589–600. doi: 10.1007/s15010-017-1031-2
  • El-Sadr WM, Vasan A, El-Mohandes A. Facing the New covid-19 Reality. N Engl J Med. 2023;388(5):385–387. doi: 10.1056/NEJMp2213920
  • WHO Coronavirus (COVID-19) Dashboard. [Last read 20th Aug 2023]. https://covid19.who.int.
  • Feikin DR, Higdon MM, Abu-Raddad LJ, et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet Lond Engl. 2022;399:924–944. doi: 10.1016/S0140-6736(22)00152-0
  • Tan J, Liu N, Guo T, et al. Genetic predisposition to COVID-19 may increase the risk of hypertension disorders in pregnancy: a two-sample Mendelian randomization study. Pregnancy Hypertens. 2021;26:17–23. doi: 10.1016/j.preghy.2021.08.112
  • Davies NM, Holmes MV, Davey SG. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601. doi: 10.1136/bmj.k601
  • Smith GD, Ebrahim S. ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1–22. doi: 10.1093/ije/dyg070
  • Lawlor DA, Harbord RM, Sterne JAC, et al. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133–1163. doi: 10.1002/sim.3034
  • Bowden J, Davey SG, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–525. doi: 10.1093/ije/dyv080
  • Li C, Liu J, Lin J, et al. COVID-19 and risk of neurodegenerative disorders: A Mendelian randomization study. Transl Psychiatry. 2022;12(1):283. doi: 10.1038/s41398-022-02052-3
  • Li J, Bai H, Qiao H, et al. Causal effects of COVID-19 on cancer risk: a Mendelian randomization study. J Med Virol. 2023;95(4):e28722. doi: 10.1002/jmv.28722
  • Miao J, Gu X, Shi R. COVID-19 is associated with the risk of cardiovascular disease death: a two-sample Mendelian randomization study. Front Cardiovasc Med. 2022;9:974944. doi: 10.3389/fcvm.2022.974944
  • Verma A, Tsao NL, Thomann LO, et al. A phenome-wide association study of genes associated with COVID-19 severity reveals shared genetics with complex diseases in the million veteran program. PLoS Genet. 2022;18(4):e1010113. doi: 10.1371/journal.pgen.1010113
  • Li Y, Liu L, Huang Y, et al. Association of ABO polymorphisms and pancreatic Cancer/Cardiocerebrovascular disease: a meta-analysis. BMC Med Genet. 2020;21(1):41. doi: 10.1186/s12881-020-0975-8
  • Zhang J, Wu F, Chen S, et al. Genetic predisposition to severe COVID-19 might increase the risk of stroke: a two-sample Mendelian randomization study. Front Genet. 2022;13:895211. doi: 10.3389/fgene.2022.895211
  • Velavan TP, Pallerla SR, Rüter J, et al. Host genetic factors determining COVID-19 susceptibility and severity. EBioMedicine. 2021;72:103629. doi: 10.1016/j.ebiom.2021.103629
  • dos Santos ACM, dos Santos BRC, dos Santos BB, et al. Genetic polymorphisms as multi-biomarkers in severe acute respiratory syndrome (SARS) by coronavirus infection: a systematic review of candidate gene association studies. Infect Genet Evol. 2021;93:104846. doi: 10.1016/j.meegid.2021.104846
  • Brandt JS, Hill J, Reddy A, et al. Epidemiology of coronavirus disease 2019 in pregnancy: risk factors and associations with adverse maternal and neonatal outcomes. Am J Obstet Gynecol. 2021;224(4):e389.1–.e389.9. doi: 10.1016/j.ajog.2020.09.043
  • Chornock R, Iqbal SN, Wang T, et al. Incidence of hypertensive disorders of pregnancy in women with COVID-19. Am J Perinatol. 2021;38(8):766–772. doi: 10.1055/s-0041-1727167
  • Gurol-Urganci I, Jardine JE, Carroll F, et al. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study. Am J Obstet Gynecol. 2021;225(5):.e522.1–.e522.11. doi: 10.1016/j.ajog.2021.05.016
  • Grechukhina O, Greenberg V, Lundsberg LS, et al. Coronavirus disease 2019 pregnancy outcomes in a racially and ethnically diverse population. Am J Obstet Gynecol MFM. 2020;2(4):100246. doi: 10.1016/j.ajogmf.2020.100246
  • Yang R, Mei H, Zheng T, et al. Pregnant women with COVID-19 and risk of adverse birth outcomes and maternal-fetal vertical transmission: a population-based cohort study in Wuhan, China. BMC Med. 2020;18(1):330. doi: 10.1186/s12916-020-01798-1
  • Prabhu M, Cagino K, Matthews K, et al. Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study. BJOG Int J Obstet Gynaecol. 2020;127(12):1548–1556. doi: 10.1111/1471-0528.16403
  • Conde-Agudelo A, Romero R. SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022;226(1):68–89.e3. doi: 10.1016/j.ajog.2021.07.009
  • Pirjani R, Hosseini R, Soori T, et al. Maternal and neonatal outcomes in COVID-19 infected pregnancies: a prospective cohort study. J Travel Med. 2020;27(7):taaa158. doi: 10.1093/jtm/taaa158
  • Sánchez J, Espinosa J, Caballero LC, et al. COVID 19 and high pregnancy and perinatal complications in Panama. J Matern Fetal Neonatal Med. 2022;35(25):8245–8248. doi: 10.1080/14767058.2021.1967925
  • Metz TD, Clifton RG, Hughes BL, et al. Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19). Obstet Gynecol. 2021;137(4):571–580. doi: 10.1097/AOG.0000000000004339
  • Mahajan NN, Kesarwani S, Kumbhar P, et al. Increased risk of early-onset preeclampsia in pregnant women with COVID-19. Hypertens Pregnancy. 2023;42(1):2187630. doi: 10.1080/10641955.2023.2187630
  • Lai J, Romero R, Tarca AL, et al. SARS-CoV-2 and the subsequent development of preeclampsia and preterm birth: evidence of a dose-response relationship supporting causality. Am J Obstet Gynecol. 2021;225(6):689–693.e1. doi: 10.1016/j.ajog.2021.08.020
  • Prasad S, Kalafat E, Blakeway H, et al. Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy. Nat Commun. 2022;13(1):2414. doi: 10.1038/s41467-022-30052-w
  • Shafiee A, Gargari OK, Athar MMT, et al. COVID-19 vaccination during pregnancy: a systematic review and meta-analysis. Bmc Pregnancy Childbirth. 2023;23(1):45. doi: 10.1186/s12884-023-05374-2
  • Theiler RN, Wick M, Mehta R, et al. Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy. Am J Obstet Gynecol MFM. 2021;3(6):100467. doi: 10.1016/j.ajogmf.2021.100467
  • Piekos SN, Hwang YM, Roper RT, et al. Effect of COVID-19 vaccination and booster on maternal–fetal outcomes: a retrospective cohort study. Lancet Digit Health. 2023;5(9):e594–e606. doi: 10.1016/S2589-7500(23)00093-6
  • Irani RA, Xia Y. The functional role of the renin–angiotensin System in pregnancy and preeclampsia. Placenta. 2008;29(9):763–771. doi: 10.1016/j.placenta.2008.06.011
  • Khlestova GV, AYu R, Nizyaeva NV, et al. Dynamics of renin, angiotensin II, and angiotensin (1–7) during pregnancy and predisposition to hypertension-associated complications. Bull Exp Biol Med. 2018;165(4):438–439. doi: 10.1007/s10517-018-4188-5
  • Li G, He X, Zhang L, et al. Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19. J Autoimmun. 2020;112:102463. doi: 10.1016/j.jaut.2020.102463
  • Miesbach W. Pathological role of angiotensin II in severe COVID-19. TH Open. 2020;4(02):e138–e144. doi: 10.1055/s-0040-1713678
  • Magee LA, Nicolaides KH, von Dadelszen PP, et al. Preeclampsia. N Engl J Med. 2022;386(19):1817–1832. doi: 10.1056/NEJMra2109523
  • Seethy AA, Singh S, Mukherjee I, et al. Potential SARS-CoV-2 interactions with proteins involved in trophoblast functions – an in-silico study. Placenta. 2021;103:141–151. doi: 10.1016/j.placenta.2020.10.027
  • Richmond RC, Smith GD. Mendelian randomization: concepts and scope. Cold Spring Harb Perspect Med. 2022;12(1):a040501. doi: 10.1101/cshperspect.a040501